Six Years Later, Many Suspect Papers Remain Unflagged Six Years Later, Many Suspect Papers Remain Unflagged
When the University of Colorado at Denver completed an investigation in 2015 into the work of a former faculty member, the school recommended that nine papers be corrected or retracted.Retraction Watch (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - June 4, 2021 Category: Urology & Nephrology Tags: Urology News Source Type: news
Everyday Chemicals Are Linked to Declines in Human Fertility Everyday Chemicals Are Linked to Declines in Human Fertility
Chemicals that pervade our modern world are contributing to a decades-long decline in fertility and could pose health risks even into future generations, writes a New York epidemiologist in a new book.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 12, 2021 Category: Urology & Nephrology Tags: Urology News Source Type: news
Declining Sperm Count Tied to Chemicals in the Environment Declining Sperm Count Tied to Chemicals in the Environment
Chemicals that pervade our modern world are contributing to a decades-long decline in fertility and could pose health risks even into future generations, writes a New York epidemiologist in a new book.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 9, 2021 Category: Urology & Nephrology Tags: Urology News Source Type: news
Herbal Extract Promising as Male Contraceptive in Animal Trials Herbal Extract Promising as Male Contraceptive in Animal Trials
A compound distilled from an herb used in traditional Chinese medicine could become a birth control pill for men if the results in animals are confirmed in humans.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - March 16, 2021 Category: Urology & Nephrology Tags: Urology News Source Type: news
Testosterone Decline After Steroid Abuse Shown by New Biomarker Testosterone Decline After Steroid Abuse Shown by New Biomarker
Levels of insulinlike factor 3 drop noticeably in men who have abused anabolic androgenic steroids.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - March 11, 2021 Category: Urology & Nephrology Tags: Diabetes & Endocrinology News Source Type: news
6 Meds That Can Mess With Your Patient's Sex Life 6 Meds That Can Mess With Your Patient's Sex Life
It is not uncommon for patients to skip medications that disrupt their sex lives. Here are six classes of drugs that warrant extra patient education.Medscape Urology (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - January 20, 2021 Category: Urology & Nephrology Tags: Urology Commentary Source Type: news
FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer
Relugolix is an oral form of androgen deprivation therapyFDA Approvals (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - December 18, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
New Drug for Prostate Cancer: Ipatasertib, an AKT Inhibitor New Drug for Prostate Cancer: Ipatasertib, an AKT Inhibitor
When used in combination with abiraterone, the new drug showed activity in metastatic castration-resistant prostate cancer in the IPATential 150 trial.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 24, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Nivo-Cabo Combo Joins Advanced RCC Treatment Ranks Nivo-Cabo Combo Joins Advanced RCC Treatment Ranks
The PD-1 inhibitor/TKI combination is the latest to show superior survival in comparison with sunitinib as first-line therapy for patients with metastatic renal cell carcinoma (RCC).Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 21, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
A Call to Test Men With Prostate Cancer for COVID-19 A Call to Test Men With Prostate Cancer for COVID-19
A team of New York City urologists proposes that men with prostate cancer get tested for COVID-19 because of their vulnerabilities to the infection.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - August 12, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Gene Therapy Promising in BCG-Unresponsive Bladder Cancer Gene Therapy Promising in BCG-Unresponsive Bladder Cancer
An investigative intravesical viral gene therapy may offer a bladder-sparing alternative for some patients with high-grade, nonmuscle invasive bladder cancer who have few options, results from a phase 3 study show.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - August 6, 2020 Category: Urology & Nephrology Tags: Urology News Source Type: news
ADT for Prostate Cancer: Concern That Injections Often Given Late ADT for Prostate Cancer: Concern That Injections Often Given Late
A new analysis finds that most injections are given outside of their recommended time frame, and there is concern that rising hormone levels could compromise outcomes.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - July 30, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Mitomycin Approved for Low-Grade Upper Tract Urothelial Cancer Mitomycin Approved for Low-Grade Upper Tract Urothelial Cancer
The Food and Drug Administration has approved mitomycin, the first therapy for adults with low-grade upper tract urothelial cancer.FDA Approvals (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 16, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Alert Source Type: news
A Failed Strategy for an Effective Bladder Cancer Drug A Failed Strategy for an Effective Bladder Cancer Drug
When the number of doses of BCG for high-grade non-muscle invasive bladder cancer was cut, outcomes were inferior in a randomized clinical trial.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - February 17, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Screening Decision Aids No Substitute for Patient-Doc Discussion Screening Decision Aids No Substitute for Patient-Doc Discussion
When it comes to prostate cancer screening, decision aids cannot replace a conversation between a man and his physician.Medscape Urology (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 9, 2019 Category: Urology & Nephrology Tags: Urology Commentary Source Type: news
